SR
Swapnil Ravikiran Bhagirath
About Swapnil Ravikiran Bhagirath
Data last updated:
Swapnil Ravikiran Bhagirath is a Director at Currec Pharma Private Limited (since 2023). The company operates in Paper. Currec Pharma Private Limited reported revenue of ₹2.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Currec Pharma Private Limited U21001MH2023PTC415905 | Director | 22 Dec 2023 | 2023 | ₹2.8 Lakh (FY 2025) | Active |
Board colleagues of Swapnil Ravikiran Bhagirath
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amol Vinod Satav | 10436839 | Currec Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Swapnil Ravikiran Bhagirath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swapnil Ravikiran Bhagirath
Swapnil Ravikiran Bhagirath currently holds 1 directorship: Currec Pharma Private Limited (Director, since 22 Dec 2023, revenue ₹2.8 Lakh (FY 2025)).
Swapnil Ravikiran Bhagirath was first appointed on 22 Dec 2023 as Director at Currec Pharma Private Limited.
The current boards of Swapnil Ravikiran Bhagirath's companies include Amol Vinod Satav (Currec Pharma Private Limited).